Form 4 for NUTX Nutex Health Inc.

Accepted 2026-03-11 00:00:00 ET · period of report 2026-03-09 · accession 0001486189-26-000003 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
DI	2026-03-11	2026-03-10	NUTX	Luqman Elisa V	CLO - SEC	F - Tax	$86.22	-784	2,370	-25%	-$67.6K
DI	2026-03-11	2026-03-10	NUTX	Luqman Elisa V	CLO - SEC	M - OptEx	$0.00	+2,084	3,154	+195%	$0
D	2026-03-11	2026-03-10	NUTX	Luqman Elisa V	CLO - SEC	M - OptEx	$0.00	+1,525	4,441	+52%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2026-03-10	F	D	784	$86.22	2,370	I See note (4)	—	—	(F2) Of the 2,084 shares issued subsequent to vesting, 784 shares were sold to cover tax withholding obligations. (F4) The Reporting Person directly owns 2,360 shares. Additionally, the Reporting Person indirectly owns 10 shares through their spouse, resulting in a total beneficial ownership of 2,370 shares.
2	Common	Common Stock	2026-03-10	M	A	2,084	$0.00	3,154	I See note (4)	—	—	(F1) Restricted stock units convert into common stock on a one-for-one basis. (F4) The Reporting Person directly owns 2,360 shares. Additionally, the Reporting Person indirectly owns 10 shares through their spouse, resulting in a total beneficial ownership of 2,370 shares.
3	Derivative	Restricted Stock Units	2026-03-10	M	A	1,525	$0.00	4,441	D	$0.00 · 2027-03-01 to 2029-03-01	1,525 Common Stock	(F1) Restricted stock units convert into common stock on a one-for-one basis. (F3) On March 11, 2026, the Reporting Person was granted 1,525 RSUs, which vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029.